Genomic Classifiers in Personalized Prostate Cancer Radiotherapy Approaches
This journal activity provides practitioners with a comprehensive review of the data to date, as well as expert opinions, on the incorporation of genomic classifiers into prostate cancer risk stratification in clinical practice as well as future translational directions. This will help practitioners appropriately interpret genomic classifiers in prostate cancers with regard to their prognostic and predictive value based on available literature to date. .
Please visit https://www.redjournal.org/article/S0360-3016(22)03691-4/fulltext to read the related journal article online.
This activity is available from June 1, 2023, through 11:59 p.m. Eastern time on May 31, 2025.
Target Audience
This course is designed to meet the interest of radiation oncologists and radiation oncology residents.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Compare prognostic and predictive value of genomic classifiers, based primarily on retrospective data, for patients with prostate cancer receiving definitive and post operative radiation.
- Evaluate expert opinions on current best practices with regard to clinical use of genomic classifiers.
Sue Yom, MD, PhD, FASTRO is employed by the University of California and receives compensation from Bristol-Myers Squibb, NRG Oncology, EMD Serono.
The person(s) above served as the developer(s) of this activity. Additionally, Education Committee had control over the content of this activity.
All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $49
- Member: $0
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until May 31, 2025, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.